Who We Are
The CIHR Canadian HIV Trials Network (CTN) is an innovative partnership of clinical investigators, physicians, nurses, people living with HIV, pharmaceutical manufacturers and others that facilitate clinical trials of the highest scientific and ethical standards for HIV and related conditions.
What We Do
Established in 1990 by the Canadian government as a cornerstone in its Federal Initiative to Address HIV/AIDS in Canada, the CTN is an innovative partnership committed to developing treatments, vaccines and a cure for HIV and AIDS through the conduct of scientifically sound and ethical clinical trials.
For all media enquiries contact:
Phone: 604 806 8306
Toll-Free: 1 800 661 4664
Our official name is: CIHR Canadian HIV Trials Network
When using an acronym, CIHR is left out: CTN
CTN Media Releases
July 11, 2016: 2016 updated CTN HIV-HCV co-infection treatment guidelines
October 30, 2014 : Announcing a major breakthrough in HIV prevention
March 4, 2014 : CTN renewal by CIHR marks 29 years of uninterrupted funding
The average age of people living with HIV in Canada is rising. CTN and BC-CfE researchers are working to understand the factors associated with aging in HIV. This story was originally published by BC-CfE.
Dr. Haneesha Mohan, CTN Postdoctoral Research Fellow at the University Health Network, describes her work on understanding the metabolic diseases and birth defects potentially caused by ARV medications.
We talked to three community members to get their unique perspectives on the pervasive impact of HIV-related stigma and what we can do to combat it
CTN Investigators Drs. Cecilia Costiniuk and Ali Jenabian publish a thorough editorial review of cannabis research in HIV and inflammation